Allergy proceedings : the official journal of regional and state allergy societies最新文献_第3页

Prevalence of avocado allergy among atopic patients. 牛油果过敏在特应症患者中的患病率。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-09-01 DOI: 10.2500/108854195778702594

G Telez-Diaz, M H Ellis, F Morales-Russo, D C Heiner

{"title":"Prevalence of avocado allergy among atopic patients.","authors":"G Telez-Diaz, M H Ellis, F Morales-Russo, D C Heiner","doi":"10.2500/108854195778702594","DOIUrl":"https://doi.org/10.2500/108854195778702594","url":null,"abstract":"A 41-year-old woman with known food allergy to avocado was treated for anaphylaxis after eating a meal containing avocado. This prompted a study to determine the prevalence of avocado induced symptoms and skin reactivity in a group of atopic patients. One hundred consecutive atopic patients with allergic rhinitis undergoing skin testing before initiation of immunotherapy were also prick skin tested to avocado. Patients with symptoms upon avocado ingestion were also assessed for specific serum IgE antibodies to avocado. Of the 100 atopic patients not selected for avocado sensitivity, 21 had positive prick skin tests to avocado. Eight of the 21 avocado skin test positive patients reported that symptoms repeatedly followed the ingestion of avocado; two reported systemic reactions, but six noted oral symptoms only. Serum IgE antibodies to avocado were elevated in seven of the eight patients reporting symptoms after eating avocado. Seven of the eight patients also reported oral symptoms following cantaloupe ingestion. Four reported similar symptoms upon eating banana. Avocado-induced symptoms occurred in 8% of 100 consecutive atopic allergic rhinitis patients unselected for avocado reactivity. Oral, and less frequently systemic, allergy symptoms appear to be more common among the atopic population than previously appreciated.","PeriodicalId":7423,"journal":{"name":"Allergy proceedings : the official journal of regional and state allergy societies","volume":"16 5","pages":"241-3"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2500/108854195778702594","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19546912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Lessons and myths regarding cross-reacting foods. 关于交叉反应食物的教训和误区。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-09-01 DOI: 10.2500/108854195778702576

R K Bush, S L Hefle

引用次数: 0

Neural receptors and asthma. 神经受体和哮喘。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-09-01 DOI: 10.2500/108854195778702585

J N Baraniuk

引用次数: 5

Tolerability of imidazole salycilate in aspirin-sensitive patients. 阿司匹林敏感患者对水杨酸咪唑的耐受性。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-09-01 DOI: 10.2500/108854195778702675

G E Senna, G Andri, A R Dama, P Mezzelani, L Andri

引用次数: 6

Jean Baptista van Helmont (1579-1644) Belgian physician and pioneer chemist. 让·巴普蒂斯塔·范·赫尔蒙特(1579-1644)，比利时医生和化学家先驱。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-09-01

S G Cohen

引用次数: 0

B2 agonists and their safety in the treatment of asthma. B2激动剂及其治疗哮喘的安全性。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-09-01 DOI: 10.2500/108854195778702693

P Fireman

{"title":"B2 agonists and their safety in the treatment of asthma.","authors":"P Fireman","doi":"10.2500/108854195778702693","DOIUrl":"https://doi.org/10.2500/108854195778702693","url":null,"abstract":"Increasing prevalence and severity of asthma has prompted the development and promulgation of various national and international guidelines for asthma management in adults and children. All of these guidelines agree that short-acting inhaled B2-agonists on demand represent the most appropriate initial bronchodilator therapy. However, there has been considerable debate as to the merit of maintenance bronchodilator therapy with regular inhaled B2-agonists, either the short acting agents, or the newer long-acting inhaled B2-agonist, salmeterol. Of concern is the possibility that there are detrimental effects of chronic B2-agonist bronchodilator treatment. Do these B2-agonists have the potential to worsen asthma control and thereby have an adverse impact by contributing to the increased prevalence and severity of asthma? This article will review the pertinent literature with regard to the safety of the B2-agonists, which are appropriate but not perfect medications for asthmatics. It will also put this information in perspective for the clinician and provide this author's recommendations for their use in managing the manifestations of chronic and recurrent asthma.","PeriodicalId":7423,"journal":{"name":"Allergy proceedings : the official journal of regional and state allergy societies","volume":"16 5","pages":"235-9"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2500/108854195778702693","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19546911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 13

Myelopeptides: new immunoregulatory peptides. 髓肽:新的免疫调节肽。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-07-01 DOI: 10.2500/108854195778666784

R Petrov

{"title":"Myelopeptides: new immunoregulatory peptides.","authors":"R Petrov","doi":"10.2500/108854195778666784","DOIUrl":"https://doi.org/10.2500/108854195778666784","url":null,"abstract":"Bone marrow cells of various animal species and humans produce a group of bioregulatory peptides called myelopeptides (MPs). MPs have been isolated and purified, and their physico-chemical properties have been investigated. MPs have a wide spectrum of functional activities: immunoregulatory, differentiating, and opiate-like. A new immunocorrective drug, Myelopidum, which is used effectively in clinical practice for treating diseases accompanied by immunodeficiency, has been created on the basis of MPs. Administration of Myelopidum after surgery prevents 50% to 70% of postsurgical complications, particularly postsurgery pneumonia, and also normalizes the number and balance of T-helper cells, T-suppressor cells, and B-lymphocytes in patients with chronic pulmonary diseases, resulting in a beneficial clinical effect, including a significant prolongation of remission periods. Myelopidum is also used in veterinary medicine for prophylaxis and treatment of pneumonia and enteritis in newborn and young animals. The primary structure of several myelopeptides is established. The functional activities of two, MP-1 (Phe-Leu-Gly-Phe-Pro-Thr) and MP-2 (Leu-Val-Val-Tyr-Pro-Trp), are being investigated.","PeriodicalId":7423,"journal":{"name":"Allergy proceedings : the official journal of regional and state allergy societies","volume":"16 4","pages":"177-84"},"PeriodicalIF":0.0,"publicationDate":"1995-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2500/108854195778666784","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19547023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Modified allergen immunotherapy: effect on immunoglobulin E production. 改良过敏原免疫疗法:对免疫球蛋白E产生的影响。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-07-01 DOI: 10.2500/108854195778666883

A A Babakhin, R M Khaitov, R V Petrov

引用次数: 1

Al-Afdal (1169-1225) Arab Sultan of Damascus and Egypt. 阿夫达尔(1169-1225)，大马士革和埃及的阿拉伯苏丹。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-07-01

S G Cohen

引用次数: 0

Henri de Mondeville (1260-1320) French pioneer surgeon. 亨利·德·蒙德维尔（1260-1320），法国外科医生先驱。

Allergy proceedings : the official journal of regional and state allergy societies Pub Date : 1995-07-01

S G Cohen

引用次数: 0